If you're interested in learning more, you can follow along on the most recent developments at clinicaltrials[dot]gov and at the company's (American Gene Technologies) website at americangene[dot]com.
The link to view the clinical trial data is [think before following links] https://clinicaltrials.gov/search?cond=hiv&term=agt-103. Here you can see the sequence of trials that the company is sponsoring to test its treatment. Thus far, the trials are taking place in Washington, DC (at Georgetown University Hospital and Washington Hospital Center). The study includes only 7 trial participants who were included by invitation only.
The trials are still in Phase 1. As many of you know, there are generally 3 phases to clinical trials. Phase I usually tests the safety of the treatment and is conducted on a small number of people, hence the 7 here. To date, it seems that the 7 trial participants were infused with the edited T-cells (Phase Ia). Phase 1b is underway in which the 7 participants will stop their ARV therapy and be closely monitored for adverse effects and for HIV rebound. According to clinicaltrials, Phase 1b is expected to be completed in July 2025 -- so in a few months, although we will not have the results of this phase for some time after the trials phase closes.
If the trial proceeds to Phase 2, a larger pool of people at various sites throughout the country will be able to participate and finally in Phase 3 an even larger number. Hopefully, the trials will be structured to include a diverse participant pool, including women and trans individuals.
Given that Phase 1 may conclude this July, it is still a while away from knowing how effective this treatment might be (Phase 3), but the FDA has been known to stop a trial if the results are so positive that it feels a greater number of people will benefit without having to wait for the trial to end. It's rare, but has happened.
The company also maintains an HIV clinical trial timeline at this site: [think before following links] https://www.americangene.com/milestones/hiv-cure-countdown/